HealthCor Management’s Instil Bio TIL Stock Holding History

HealthCor Management’s Portfolio TIL Stock Details TIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-10,000	Closed	-$5.02M	–	103
2021 Q1	$5.02M	Buy	+10,000	New	+$5.13M	0.18%	65

Other funds holding TIL

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

HealthCor Management's TIL Position: Q2 2021 in Review

HealthCor Management sold out of Instil Bio (TIL) in Q2 2021, closing a stake of 10,000 shares — an estimated $5.02M sold.

HealthCor Management first reported a position in TIL in Q1 2021 and held it in 1 quarter. The position peaked at $5.02M in Q1 2021. 62 funds tracked by Wall St. Rank hold TIL as of Q2 2021.

HealthCor Management reported no remaining Instil Bio position as of Q2 2021 after selling out during the quarter.
HealthCor Management sold 10,000 Instil Bio shares in Q2 2021, an estimated $5.02M.
HealthCor Management first reported a position in Instil Bio in Q1 2021 and held it in 1 quarter.
HealthCor Management's Instil Bio position peaked at $5.02M in Q1 2021.
62 funds tracked by Wall St. Rank held Instil Bio as of Q2 2021.

Based on HealthCor Management's 13F filing for Q2 2021, filed 16 Aug 2021.